NMPA Approval

Rosuvastatin Calcium Tablets

Approval Number

国药准字HJ20191003

Registration Date

October 25, 2022

Previous Approval Numbers

H20191003

Drug Information

Generic Name

瑞舒伐他汀钙片

Dosage Form

片剂

Strength

5mg（以瑞舒伐他汀计）

Drug Type

化学药品

Registration Date

October 25, 2022

Expiry Date

October 24, 2027

Company Address

Verovskova ulica 57,1526 Ljubljana,Slovenia

Company Address

Verovskova ulica 57,1526 Ljubljana,Slovenia

Empowering clinical research with data-driven insights and AI-powered tools.

瑞舒伐他汀钙片 - NMPA 批准文号 | MedPath